You are here

  • Home
  • Archive
  • Volume 67, Issue 8
  • Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study

Article info

Article menu
Download PDFPDF
Extended report
Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study

Authors

  1. G A W Bruyn, Medisch Centrum Leeuwarden (Zuid), Afd. Reumatologie, Leeuwarden, 8934 AD, The Netherlands; gawbruyn{at}wxs.nl
View Full Text

Citation

Bruyn GAW, Tate G, Caeiro F, et al
Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study
Annals of the Rheumatic Diseases 2008;67:1090-1095.

Publication history

  • Accepted November 18, 2007
  • First published November 23, 2007.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2008 BMJ Publishing Group and European League Against Rheumatism